IP Library › Granted Patent US 9,222,097
Granted Patent B2
US 9,222,097 · App. 11/794,759 · Granted Dec 29, 2015

Functional viral vectors for the overexpression or extinction of particular genes in plants, and applications thereof

Inventors: Christophe Brugidou (Pignan, FR); Christelle Sire (Barcelona, ES)
Assignee: INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (IRD)
C12N15/8203C12N15/8218
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,222,097
App. No.
11/794,759
Granted
Dec 29, 2015
Kind
B2
Abstract

The invention relates to the use of genes which, in plants, encode proteins with a functional diversity in terms of silencing, comprising the selection of the gene with the level of effectiveness in order to construct a plant viral vector having the function of overexpressing or silencing particular genes.

Claims (14)

1. A method of selecting RYMV (Rice Yellow Mottle Virus) P1 proteins having PTGS (Post Transcriptional Gene Silencing) suppressor activity, said method comprising:

cloning genes encoding RYMV P1 proteins downstream of a RYMV 35S promoter to form expression cassettes, said expression cassettes containing a GUS reporter gene,

inoculating the expression cassettes encoding the suppressor proteins by biolistics onto rice leaves,

mechanically inoculating RYMV virus into said rice leaves,

assaying the viral load by DAS-ELISA using a polyclonal antibody directed against the virus,

visualizing the restoration of expression of the GUS reporter gene encoding beta-glucoronidase by histochemical assay,

quantifying the restoration of expression of the GUS reporter gene by assaying the enzymatic activity of GUS,

detecting siRNAs as evidence of PTGS by Northern blotting, and

selecting P1 proteins having PTGS suppressor activity.

2. The method of claim 1 , wherein the RYMV P1 protein is selected from a Tz3 RYMV isolate, a Tz8 RYMV isolate, an Mg1 RYMV isolate, and an CI63 RYMV isolate.

3. The method of claim 2 , wherein the RYMV P1 protein is a CI63 RYMV isolate or a Tz3 RYMV isolate.

4. The method of claim 2 , wherein the Tz8 P1 protein is selected for an intermediate level of effectiveness for PTGS suppression, and the Mg1 P1 protein is selected for a low level of effectiveness in PTGS suppression.

5. A viral vector, comprising a gene encoding a RYMV P1 protein selected from a Tz3 RYMV isolate, a Tz8 RYMV isolate, an Mg1 RYMV isolate, and an CI63 RYMV isolate, wherein said vector is a virus induced gene silencing (VIGS) vector and contains an insert of less than 50 bp in size, said insert being inserted in said vector in sense or antisense orientation, the target of said insert being a host mRNA transcript.

6. A viral vector, comprising a gene encoding a RYMV P1 protein selected from a Tz3 RYMV isolate, a Tz8 RYMV isolate, an Mg1 RYMV isolate, and an CI63 RYMV isolate, wherein said vector is a viral protein expression vector and contains an insert of greater than 700 bp of a gene of interest to be overexpressed, said insert being inserted into the replicative ORF 2a and 2b of RYMV.

Assignments (2)
CHANGE OF ADDRESS Recorded Oct 7, 2015
From: INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (IRD)
To: INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (IRD)
Reel/Frame 036807/0326 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2007
From: BRUGIDOU, CHRISTOPHE; SIRE, CHRISTELLE
To: INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (IRD)
Reel/Frame 020213/0778 →
Priority Claims (1)
FR 05 00090 · Jan 5, 2005 · national
Continuity (1)
Related Publication 20090162832A1 · Jun 25, 2009